Literature DB >> 8409338

Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome.

A Ochs1, M Sellinger, K Haag, G Nöldge, E W Herbst, E Walter, W Gerok, M Rössle.   

Abstract

Budd-Chiari syndrome is characterized by splanchnic congestion due to obstruction of the hepatic venous outflow. A variety of treatment modalities have limited applicability due to their invasive nature, complications or low effectivity. The transjugular intrahepatic portosystemic stent-shunt (TIPS) offers a new treatment by creating an intraparenchymal duct between a main branch of the portal vein and hepatic vein i.e. the intrahepatic part of the inferior vena cava. This paper describes the treatment of two patients with fulminant and subacute Budd-Chiari syndrome treated 2 days and 2 months after the onset of clinical symptoms. It demonstrates that TIPS is a feasible treatment of Budd-Chiari syndrome that restores splanchnic blood flow, reduces collateral circulation and ascites and provides sufficient time to allow for elective liver transplantation, if indicated. Further studies are required to evaluate the effect of TIPS on liver function and survival.

Entities:  

Mesh:

Year:  1993        PMID: 8409338     DOI: 10.1016/s0168-8278(05)80249-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.

Authors:  C E Eapen; D Velissaris; M Heydtmann; B Gunson; S Olliff; E Elias
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

3.  Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome.

Authors:  M D Uhl; D B Roth; C A Riely
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

4.  Budd-Chiari syndrome: current management options.

Authors:  D P Slakey; A S Klein; A C Venbrux; J L Cameron
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

5.  Imaging and interventions in Budd-Chiari syndrome.

Authors:  Amar Mukund; Shivanand Gamanagatti
Journal:  World J Radiol       Date:  2011-07-28

Review 6.  [Acute hepatic vascular complications].

Authors:  A Ochs
Journal:  Internist (Berl)       Date:  2011-07       Impact factor: 0.743

Review 7.  The use and misuse of transjugular intrahepatic portasystemic shunts.

Authors:  A J Sanyal
Journal:  Curr Gastroenterol Rep       Date:  2000-02

8.  Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting.

Authors:  N C Fisher; I McCafferty; M Dolapci; M Wali; J A Buckels; S P Olliff; E Elias
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

9.  Treatment of Budd-Chiari syndrome with transjugular intrahepatic portosystemic shunt (TIPS).

Authors:  R Corso; M Intotero; M Solcia; M C Castoldi; A Rampoldi
Journal:  Radiol Med       Date:  2008-07-09       Impact factor: 3.469

10.  Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment.

Authors:  Deepak N Amarapurkar; Sundeep J Punamiya; Nikhil D Patel
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.